Correlation Between Cullinan Oncology and Phathom Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Phathom Pharmaceuticals, you can compare the effects of market volatilities on Cullinan Oncology and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Phathom Pharmaceuticals.
Diversification Opportunities for Cullinan Oncology and Phathom Pharmaceuticals
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cullinan and Phathom is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Phathom Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Phathom Pharmaceuticals
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 0.46 times more return on investment than Phathom Pharmaceuticals. However, Cullinan Oncology LLC is 2.16 times less risky than Phathom Pharmaceuticals. It trades about -0.25 of its potential returns per unit of risk. Phathom Pharmaceuticals is currently generating about -0.23 per unit of risk. If you would invest 1,561 in Cullinan Oncology LLC on August 24, 2024 and sell it today you would lose (339.00) from holding Cullinan Oncology LLC or give up 21.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Phathom Pharmaceuticals
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Phathom Pharmaceuticals |
Cullinan Oncology and Phathom Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Phathom Pharmaceuticals
The main advantage of trading using opposite Cullinan Oncology and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.| Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Hookipa Pharma | Cullinan Oncology vs. Cingulate Warrants | Cullinan Oncology vs. SAB Biotherapeutics |
| Phathom Pharmaceuticals vs. Lyra Therapeutics | Phathom Pharmaceuticals vs. Hookipa Pharma | Phathom Pharmaceuticals vs. Cingulate Warrants | Phathom Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |